Clinical Experience With Polyclonal IgM-Enriched Immunoglobulins in a Group of Patients Affected by Sepsis After Cardiac Surgery

Conclusions: The polyclonal IgM-enriched immunoglobulins did not significantly reduce the mortality rate in the overall study population. However, in the subgroup of patients with severe sepsis, they improved the survival rate significantly.